Your browser doesn't support javascript.
loading
Prognostic significance of 18F-FDG PET/CT indices in metastatic renal cell cancer and evaluation of revised IMDC risk model by including 18F-FDG PET-CT parameters.
Arikan, Rukiye; Ozguven, Salih; Telli, Tugba Akin; Isik, Selver; Demircan, Nazim Can; Basoglu, Tugba; Yasar, Alper; Celebi, Abdussamet; Filizoglu, Nuh; Ustun, Hilal Sagiroglu; Tinay, Ilker; Ones, Tunc; Turoglu, Halil Turgut; Erdil, Tanju Yusuf; Ozturk, Mehmet Akif; Ercelep, Ozlem; Bayoglu, Vedat; Kostek, Osman; Dane, Faysal; Yumuk, Perran Fulden.
Afiliação
  • Arikan R; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Ozguven S; Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Telli TA; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Isik S; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Demircan NC; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Basoglu T; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Yasar A; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Celebi A; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Filizoglu N; Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Ustun HS; Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Tinay I; Department of Urology, Marmara University School of Medicine, Istanbul, Turkey.
  • Ones T; Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Turoglu HT; Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Erdil TY; Department of Nuclear Medicine, Marmara University School of Medicine, Istanbul, Turkey.
  • Ozturk MA; Department of Internal Medicine, Division of Medical Oncology, Bahcesehir University School of Medicine, Istanbul, Turkey.
  • Ercelep O; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Bayoglu V; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Kostek O; Department of Internal Medicine, Division of Medical Oncology, Marmara University School of Medicine, Istanbul, Turkey.
  • Dane F; Department of Internal Medicine, Division of Medical Oncology, Acibadem University School of Medicine, Istanbul, Turkey.
  • Yumuk PF; Department of Internal Medicine, Division of Medical Oncology, Koc University School of Medicine, Istanbul, Turkey.
Acta Radiol ; 64(5): 2040-2049, 2023 May.
Article em En | MEDLINE | ID: mdl-36447438
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Radiol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Radiol Ano de publicação: 2023 Tipo de documento: Article